| Document Date: 2008-03-07 11:41:50
Open Document File Size: 156,23 KBShare Result on Facebook
City South San Francisco / / Company The New York Times Company / Amgen / Option For / Cytokinetics / / Currency USD / / Event FDA Phase / M&A / Business Partnership / / IndustryTerm experimental drug / treatment for heart failure / biotechnology giant / / MedicalCondition heart diseases / disease / kidney disease / heart failure / anemia / / Person Roger Perlmutter / ANDREW POLLACK / Robert I. Blum / / / Position president / executive vice president for research and development / / Product Aranesp / Heart Failure Drug / CK-1827452 / / ProvinceOrState California / / PublishedMedium The New York Times / / Technology biotechnology / / URL www.nytimes.com / /
SocialTag |
REPRINTED WITH PERMISSION Business Day